Figure 6.

Effect of ASP on histopathology status of HFD‐injured liver. (a) HE assessment. With increasing dosage of ASP, ballooning lesions and macro‐vesicular steatosis scale decreased (scale bar 20 μm). (b) Oil Red O staining assessment in vivo. ASP reduced red lipid in a dose‐dependent manner (scale bar 10 μm). (c) Nile red staining assessment in vivo. ASP alleviated red fluorescent intensity in a dose‐dependent manner (scale bar 50 μm)